Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases

Departament de Psicobiologia i Metodologia de les Ciències de la Salut

Conjunt de dades

1 Article

1 resultats

Filtre

2019
Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases
Sampayo-Cordero, M., Miguel-Huguet, B., Pardo-Mateos, A., Malfettone, A., Pérez-García, J., Llombart-Cussac, A., Cortés, J., Moltó-Abad, M., Muñoz-Delgado, C., Pérez-Quintana, M. & Pérez-López, J., 21 d’oct. 2019, In: Orphanet Journal of Rare Diseases. 14, 1, 230.
Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

Accés Obert
16 Cites (Scopus)